Posfrea 0.075 MG per 1.5 ML Injection

RxCUI
2688837
RxNorm name
Posfrea 0.075 MG per 1.5 ML Injection
Display name
Posfrea 0.075 MG per 1.5 ML Injection
Full name
Posfrea 0.075 MG per 1.5 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
posfreaPALONOSETRONAvyxa Pharma, LLC13a201ba-c86d-48c5-a0e1-a3e0b4e6a2a72025-04-29Warnings, Adverse reactionsExact identifier
rxcui: 2688837

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
13a201ba-c86d-48c5-a0e1-a3e0b4e6a2a7Posfrea 0.075 MG per 1.5 ML InjectionSY7These highlights do not include all the information needed to use POSFREA safely and effectively. See full prescribing information for POSFREA. POSFREA TM (palonosetron) injection, for intravenous use Initial U.S. Approval: 200320250429
13a201ba-c86d-48c5-a0e1-a3e0b4e6a2a7Posfrea 0.075 MG in 1.5 ML InjectionPSN7These highlights do not include all the information needed to use POSFREA safely and effectively. See full prescribing information for POSFREA. POSFREA TM (palonosetron) injection, for intravenous use Initial U.S. Approval: 200320250429
13a201ba-c86d-48c5-a0e1-a3e0b4e6a2a71.5 ML palonosetron 0.05 MG/ML Injection [Posfrea]SBD7These highlights do not include all the information needed to use POSFREA safely and effectively. See full prescribing information for POSFREA. POSFREA TM (palonosetron) injection, for intravenous use Initial U.S. Approval: 200320250429